The Global β-Galactosidase Market was valued at USD 196.8 Million in 2023 and is projected to reach USD 282.5 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period (2024-2029). This expansion is driven by increasing lactose intolerance cases worldwide, growing demand for dairy alternatives, and expanding pharmaceutical applications including glycoprotein research and diagnostic testing.

As food technologists and biopharmaceutical manufacturers seek more efficient lactose hydrolysis solutions, leading enzyme producers are accelerating innovation in thermal stability, pH tolerance, and application-specific formulations. Here we analyze the Top 10 Companies in the β-Galactosidase Industry—biotechnology innovators and specialty enzyme developers transforming dairy processing and medical applications.

---

🔟 1. Royal DSM NV

Headquarters: Heerlen, Netherlands
Key Offerings: Maxilact® LG2000, GODO-YNL2 series

DSM’s enzyme division leads in microbial innovation with high-efficiency β-galactosidase formulations for industrial dairy processing. The company’s latest Maxilact® variants demonstrate 30% greater activity than standard lactase enzymes.

Strategic Developments:

• Pioneering immobilized enzyme technology for continuous processing
• Expansion of GMP-certified production facilities in Singapore
• Strategic alliance with major Asian dairy consortiums

Download FREE Sample Report: β-Galactosidase Market – View in Detailed Research Report

---

9️⃣ 2. Novozymes A/S

Headquarters: Bagsværd, Denmark
Key Offerings: Lactozym® Flex, Ha-Lactase 5200

This biotechnology leader combines fungal and bacterial fermentation expertise to produce high-performance β-galactosidase enzymes with exceptional temperature stability (maintaining 80% activity at 60°C).

Strategic Developments:

• Launched next-generation thermostable lactase in 2023
• Commissioned new enzyme production facility in Brazil

---

8️⃣ 3. IFF Health & Biosciences (DuPont Nutrition)

Headquarters: Wilmington, Delaware, USA
Key Offerings: Danisco® Lactase, Nurica™

The merged entity offers an expanded enzyme portfolio including pharmaceutical-grade β-galactosidase with 99.5% purity levels for diagnostic and research applications.

Strategic Developments:

• FDA-approved enzyme formulations for medical use
• Proprietary enzyme stabilization technology

---

7️⃣ 4. Chr. Hansen Holding A/S

Headquarters: Hørsholm, Denmark
Key Offerings: CHY-MAX® XTREME, HA-LA ColdActive

Specializing in cold-active enzymes, Chr. Hansen’s β-galactosidase maintains optimal performance at refrigeration temperatures—critical for fresh dairy products.

Strategic Developments:

• €150M investment in enzyme production capacity
• Development of allergen-free enzyme formulations

Download FREE Sample Report: β-Galactosidase Market – View in Detailed Research Report

---

6️⃣ 5. Amano Enzyme Inc.

Headquarters: Nagoya, Japan
Key Offerings: Lactase F “Amano” 50, Lactase S

Japan’s premier enzyme manufacturer provides specialist β-galactosidase preparations optimized for Asian diets and traditional fermented dairy products.

Strategic Developments:

• New GMP+ certified manufacturing lines
• Expanded R&D focus on infant nutrition applications

---

5️⃣ 6. Advanced Enzyme Technologies Ltd.

Headquarters: Thane, India
Key Offerings: Enzose-FL, Lactase AET

India’s enzyme market leader offers cost-optimized β-galactosidase solutions with particular strength in emerging economies and tropical climate stability.

Strategic Developments:

• Commissioned new fermentation facility in 2023
• Strategic partnerships with regional dairy producers

---

4️⃣ 7. Specialty Enzymes & Probiotics

Headquarters: Chino, California, USA
Key Offerings: SEP-LACTASE, Ultra-Dairyzyme

This California innovator focuses on synergistic enzyme-probiotic formulations that enhance lactose digestion and gut health simultaneously.

Strategic Developments:

• GRAS notification for novel enzyme blends
• Expansion into medical food applications

---

3️⃣ 8. SternEnzym GmbH & Co. KG

Headquarters: Ahrensburg, Germany
Key Offerings: SternZYM GA-2000, LactoStern

European enzyme authority providing premium β-galactosidase preparations with extended shelf-life stabilization technologies.

Strategic Developments:

• New organic-certified enzyme lines
• Advanced encapsulation delivery systems

---

2️⃣ 9. Enzyme Development Corporation

Headquarters: New York, USA
Key Offerings: Lactase 3000, Beta-Gal Extra

US-based specialist offering customizable enzyme solutions for industrial applications with proprietary immobilization techniques.

Strategic Developments:

• New enzyme reactor systems for whey processing
• Expansion into functional food ingredients

---

1️⃣ 10. Shandong Longda Bio-Products Co., Ltd.

Headquarters: Linyi, China
Key Offerings: LD-Galactosidase, Milkzyme

China’s fastest-growing enzyme producer specializing in high-activity β-galactosidase formulations for domestic dairy processors.

Strategic Developments:

• Major capacity expansion completed in 2023
• Government-supported R&D initiatives

Get Full Report Here: β-Galactosidase Market – View in Detailed Research Report

---

🌍 Market Outlook: Next-Generation Enzyme Innovation

The β-galactosidase sector is undergoing rapid transformation as manufacturers develop solutions for:

📈 Key Industry Trends:

• Expansion into non-dairy applications including glycoscience research
• Development of multi-enzyme systems for enhanced functionality
• Increasing adoption in diagnostic assays and biosensors
• Growth of precision fermentation production methods

These market leaders continue to drive innovation through biotechnology advances, responding to growing global demand for lactose-free products and specialized enzymatic tools in life sciences.

Get Full Report Here: β-Galactosidase Market – View in Detailed Research Report